In-vivo Antioxidant Effects of Emodin on Ischemia-Reperfusion Injury of Rat’s Skeletal Muscle Authors: Dilara Yiğit, Gürsel Levent Oktar, Hüseyin Demirtaş, Abdullah Özer, Ayşegül Küçük, Zeynep Yığman, Esra Tekin, Mustafa Arslan Published: 2026 ABSTRACT AbstractBackgroundSkeletal muscle ischemia–reperfusion (I/R) injury is a clinically significant condition characterized by oxidative stress, inflammation, and histological damage. Emodin, a natural anthraquinone derivative, has been shown to exert antioxidative, anti-inflammatory, and antiapoptotic effects in various organ systems, however its efficacy in skeletal muscle I/R injury remains unclear. This study aimed to evaluate the potential protective role of emodin in a rat model of skeletal muscle I/R injury using biochemical and histopathological assessments.MethodsTwenty-four male Wistar rats were randomly assigned to four groups: Sham (S), Emodin (E) (20 mg/kg intraperitoneal), Ischemia-Reperfusion (IR), and IR with E treatment (IR+E). Skeletal muscle I/R was induced by infrarenal aortic clamping for 45 minutes, followed by 120 minutes of reperfusion. Muscle tissue was analyzed for malondialdehyde (MDA) and glutathione (GSH) levels, as well as catalase (CAT) and superoxide dismutase (SOD) activities. Histopathological evaluation included semiquantitative scoring of muscle fiber disorganization, neutrophil infiltration, interstitial edema, and hemorrhage.ResultsThe IR group demonstrated significantly elevated MDA levels and decreased CAT activity compared with controls. E treatment markedly reduced MDA levels and partially restored CAT activity, while no significant changes were observed in SOD or GSH. Histopathological analysis showed severe disorganization, neutrophil infiltration, and edema in the IR group, which were notably attenuated by emodin, though not completely prevented.ConclusionEmodin confers partial protection against skeletal muscle I/R injury, primarily by inhibiting lipid peroxidation and partially restoring CAT activity. This study provides the first in-vivo evidence of emodin’s effects in skeletal muscle I/R, highlighting its potential as a tissue-specific antioxidant intervention and warranting further investigation of its mechanistic pathways.Keywords: ischemia-reperfusion injury, emodin, skeletal muscle, oxidative stress, MDA, SOD Introduction Ischemia-reperfusion (I/R) injury is a complex pathophysiological process initiated by the temporary interruption of blood supply to tissues, followed by the restoration of circulation. Paradoxically, the reperfusion phase often exacerbates tissue damage through the overproduction of reactive oxygen species (ROS), infiltration of inflammatory cells, and activation of apoptotic pathways. This cascade leads to significant structural and functional impairments, particularly in metabolically active tissues such as skeletal muscle.1–4 Oxidative stress resulting from I/R injury induces destructive molecular events, including lipid peroxidation, protein denaturation, and DNA damage. Lower extremity I/R injury, commonly encountered in clinical settings such as arterial embolism, aortic surgery, trauma, and acute vascular occlusion, not only causes localized tissue damage but also triggers systemic inflammatory responses that may result in multi-organ dysfunction.2,5–9 At the molecular level, I/R injury is closely associated with the activation of redox-sensitive signaling pathways, particularly nuclear factor kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (Nrf2). Excessive production of ROS during reperfusion leads to the activation of NF-κB, resulting in increased expression of proinflammatory cytokines and further exacerbation of tissue injury. In contrast, activation of the Nrf2 pathway induces the expression of endogenous antioxidant enzymes such as CAT, SOD, and GSH-related systems, thereby contributing to cellular defense mechanisms.10 Emodin, a naturally occurring anthraquinone derivative, has attracted considerable attention because of its diverse biological activities. Numerous experimental studies have demonstrated its antioxidative, anti-inflammatory, and antiapoptotic properties in various experimental models.11–21 Previous studies suggest that emodin may modulate oxidative stress and inflammatory responses by inhibiting NF-κB activation and enhancing Nrf2-mediated antioxidant pathways; however, the role of these mechanisms in skeletal muscle ischemia–reperfusion injury remains unclear.21–27 While the protective effects of emodin have been demonstrated in various organ systems, including the myocardium, kidneys, nervous tissue, and other experimental models of ischemia–reperfusion injury,24,27 limited data exist regarding its efficacy in skeletal muscle I/R models.24 To the best of our knowledge, no previous study has directly examined the effects of emodin in a skeletal muscle I/R model.21,28,29 Accordingly, the present study aimed to investigate the in-vivo antioxidant effects of emodin in a rat model of lower extremity skeletal muscle I/R injury using both biochemical and histopathological parameters. Materials and Method Animals This study was conducted on male Albino Wistar rats (250–350 g, 12 weeks old), which were obtained from the experimental research facility of Gazi University in Ankara, Turkey. All experimental procedures were approved by the Gazi University Experimental Animal Ethics Committee (G.Ü.ET-23.117) and were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication No. 85–23, revised 2011). The study was designed, conducted, and reported in compliance with the ARRIVE guidelines 2.0. All efforts were made to minimize animal suffering and to reduce the number of animals used. The animals were housed in a controlled environment with a 12-hour light/dark cycle at a temperature of 20–21°C and humidity of 45–55%, with free access to standard pellet feed and water. Drug Emodin (C15H10O5; MW: 270.24 g/mol) was obtained from Sigma-Aldrich (St. Louis, MO, USA) with a purity of 98% confirmed by high-performance liquid chromatography (HPLC). Emodin was administered intraperitoneally at a dose of 20 mg/kg just before reperfusion. The selected dose was based on previous in-vivo studies demonstrating optimal antioxidant and anti-inflammatory effects of emodin without inducing toxicity. Intraperitoneal administration was preferred due to its rapid systemic absorption and reliable bioavailability in experimental models, ensuring effective tissue exposure during the early reperfusion phase, which is critical for oxidative stress modulation.30,31 Experimental Protocol A total of 24 male Albino Wistar rats were randomly divided into four groups (n = 6 per group) (Figure 1). Each animal was considered as one independent biological replicate, and all measurements were obtained from independent observations without pseudoreplication. Anesthesia was induced via intramuscular injection of ketamine (50 mg/kg; Ketax®, Vem İlaç) and xylazine (10 mg/kg; Alfazyne®, Ege Vet). Additional doses were administered as needed to maintain a consistent surgical plane of anesthesia throughout the procedure. Overview of the experimental design and findings. (A) Experimental design and group allocation. (B) Experimental timeline including ischemia induction, emodin administration, and reperfusion. (C) Biochemical and histopathological assessment parameters. (D) Summary of main findings. (E) Overall effect of emodin on skeletal muscle ischemia-reperfusion injury. In the Sham group (S), rats underwent midline laparotomy without aortic clamping; 0.3 cc of saline was administered intraperitoneally at the 45th minute, and skeletal muscle tissue was harvested after 2 hours. In the Emodin group (E), the same procedure was followed, but 20 mg/kg of emodin was administered instead of saline. In the ischemia-reperfusion group (IR), infrarenal abdominal aorta was clamped for 45 minutes to induce ischemia, followed by 120 minutes of reperfusion. The ischemia-reperfusion + Emodin group (IR + E) underwent the same ischemia-reperfusion procedure, with emodin administered intraperitoneally just before the initiation of reperfusion. The experimental protocol, comprising 45 minutes of ischemia followed by 120 minutes of reperfusion, was implemented in accordance with established models known to effectively induce oxidative stress and inflammatory responses.32 At the end of the reperfusion period, all animals were euthanized under deep anesthesia with ketamine (100 mg/kg) and xylazine (10 mg/kg).33 Blood samples were collected via abdominal aorta puncture, and cardiac arrest was confirmed. The left and right gastrocnemius muscles were excised for biochemical and histopathological evaluation. All procedures and measurements were performed once per animal; therefore, each data point represents an independent biological observation, and no technical replicates were considered as independent samples. Histopathological Evaluation The left gastrocnemius muscle was harvested following euthanasia and fixed in 10% neutral buffered formalin for 48 hours. After fixation, the samples underwent routine tissue processing and were embedded in paraffin blocks. Sections of 4 µm thickness were obtained using a microtome (HistoCore MULTICUT, Leica, Germany) and stained with hematoxylin and eosin (H&E) for microscopic analysis. Histological evaluation was performed using a light microscope (Leica DM 4000B, Germany) at 200× and 400× magnifications. Four histopathological parameters were assessed to determine the extent of muscle injury: hemorrhage, neutrophil infiltration, disorganization and degeneration of muscle fibers, and interstitial edema. Each parameter was scored semi-quantitatively on a scale from 0 (none) to 3 (severe). In addition to comparing histopathological changes individually, the total muscle injury score, a value ranging from 0 to 12 as a sum of the scores, was also compared among the groups.34,35 Histopathological scoring was performed for each animal independently (n = 6 per group), and each measurement represents a single independent biological observation. Biochemical Evaluation The right gastrocnemius muscle was harvested immediately after euthanasia and rapidly frozen in liquid nitrogen. Tissue samples were stored at –80°C until analysis. Biochemical parameters, including MDA, GSH, SOD, and CAT, were measured using spectrophotometric methods based on established protocols. For the determination of MDA and GSH, tissue homogenization was performed in 9-fold cold trichloroacetic acid (TCA), and the supernatants were obtained after centrifugation at 4500 rpm for 15 minutes at 4°C. MDA levels were determined using the thiobarbituric acid reactive substances (TBARS) method.36 Briefly, butylhydroxytoluene (BHT) and thiobarbituric acid (TBA) were added to the supernatants, followed by incubation in a boiling water bath for 15 minutes. After centrifugation, absorbance was measured at 535 nm using a spectrophotometer.37 GSH levels were measured using the modified Ellman method.36 Supernatants were incubated with 0.3 M disodium hydrogen orthophosphate dihydrate (Na2HPO4·2H2O) and dithiobisnitrobenzoate (DTNB), and absorbance was measured at 412 nm using a spectrophotometer.36 For the determination of SOD and CAT activities, tissue homogenization was performed in cold Tris-HCl buffer (pH 7.4), followed by centrifugation at 4500 rpm for 15 minutes at 4°C. SOD activity was determined according to the method described by Sun et al38 based on the inhibition of nitroblue tetrazolium (NBT) reduction by superoxide radicals generated through the xanthine–xanthine oxidase system. Following incubation with the reaction mixture, absorbance was measured at 560 nm using a spectrophotometer. SOD activity was expressed as U/mg protein.38 CAT activity was measured according to the method described by Aebi,39 based on the decomposition of hydrogen peroxide (H2O2) monitored spectrophotometrically at 240 nm. CAT activity was expressed as U/mg protein.39 Total protein concentrations were determined using a bicinchoninic acid (BCA) protein assay kit (Pierce™ BCA Protein Assay Kit) according to the manufacturer’s instructions. SOD and CAT activities were normalized to total protein content and expressed as U/mg protein. MDA and GSH results were expressed as nmol/g tissue and were therefore not normalized to total protein content. Biochemical analyses were performed on tissue samples obtained from each individual animal (n = 6 per group), and each value represents an independent biological replicate. Statistical Analysis Statistical analysis was performed using SPSS version 23.0 (IBM Corp., Armonk, NY, USA). Each experimental group consisted of n = 6 independent biological observations. Normality of data distribution was primarily assessed using the Shapiro–Wilk test, as recommended for small sample sizes. Additionally, distribution was visually evaluated using histograms and Q–Q plots. For normally distributed data, results were expressed as mean ± standard error of the mean (SEM), and comparisons between groups were performed using one-way ANOVA followed by Tukey’s post hoc test. For non-normally distributed data, results were expressed as median (25th–75th percentiles), and comparisons were performed using the Kruskal–Wallis test followed by Dunn’s post hoc test. Exact p-values were reported where applicable, and a p-value < 0.05 was considered statistically significant. Although no formal a priori power analysis was performed, the sample size (n = 6 per group) was determined based on similar experimental studies and is consistent with the resource equation method for animal experiments, providing an acceptable error degree of freedom for ANOVA analysis. All observations represent independent biological replicates, and no pseudoreplication was performed. Results Histopathological Results Microscopic evaluation of the muscle tissues demonstrated a spectrum of morphological variations across the experimental groups. In the S group, muscle architecture remained intact, displaying well-preserved transverse striations and peripherally located nuclei (Figure 2). Similarly, the E group maintained a generally normal tissue architecture, though isolated, sparse neutrophils and mild interstitial edema were observed in some specimens (Figure 3). In contrast, the IR group exhibited profound pathological alterations. Increased eosinophilic staining and diffuse degeneration of the muscle fibers, characterized by sarcoplasmic fragmentation or vacuolization, were accompanied by intense neutrophil recruitment and marked interstitial edema in the IR group (Figure 4). On the other hand, emodin administration in the IR + E group attenuated muscle fiber injury, edema, and neutrophil infiltration induced by ischemia-reperfusion (Figure 5). Representative micrographs of H&E-stained skeletal muscle sections from the S group at low (A) and high (B) magnifications. In the longitudinal plane, skeletal muscle fibers, characterized by prominent transverse striations and peripherally located nuclei, are organized into regular fascicular patterns (A, 200× magnification; B, 400× magnification). Representative images from n = 6 independent animals per group. Representative micrographs of H&E-stained skeletal muscle sections from the E group at low (A) and high (B) magnifications. In the longitudinal plane, skeletal muscle fibers, exhibiting prominent transverse striations, are organized into regular fascicular patterns. Sparse neutrophils (indicated by wavy arrows) are noted within the interstitial space (A, 200× magnification; B, 400× magnification). Representative images from n = 6 independent animals per group. Representative micrographs of H&E-stained skeletal muscle sections from the IR group. (A) Low-magnification view (200×) demonstrating widespread disruption of skeletal muscle architecture (arrowheads) and prominent interstitial edema (asterisks). (B) High-magnification view (400×) showing marked sarcoplasmic fragmentation (arrowheads) and muscle fiber swelling, accompanied by severe interstitial edema (asterisk). (C) Low-magnification view (200×) demonstrating extensive interstitial expansion due to edema (asterisks) and marked inflammatory cell infiltration (wavy arrows). Additionally, focal vacuolization (arrow) is observed within muscle fibers. (D) High-magnification view (400×) demonstrating dense neutrophil infiltration (wavy arrows) and interstitial edema (asterisk). Representative images from n = 6 independent animals per group. Representative micrographs of H&E-stained skeletal muscle sections from the IR+E group at low (A) and high (B) magnifications. Muscle cells exhibiting impaired sarcoplasmic integrity (arrowheads) and expansion due to cellular edema show milder levels of damage. This pathology is accompanied by relatively mild interstitial edema (asterisks) (A, 200× magnification; B, 400× magnification). Representative images from n = 6 independent animals per group. Statistical analysis revealed that scores for muscle fiber disorganization and degeneration, neutrophil infiltration, and interstitial edema were significantly different among the groups (p < 0.001, p = 0.019, and p < 0.001, respectively) (Table 1). Specifically, the degree of disorganization and degeneration of muscle fibers was greater in the IR group compared to the S and E groups (p < 0.001 for both). Although the score for muscle fiber disorganization and degeneration was higher in the IR + E group than that in the S and E control groups (p = 0.003 and p < 0.001, respectively), it was found to be significantly reduced following emodin application in the IR + E group relative to the IR group (p = 0.024) (Table 1 and Figures 2–5). While neutrophil infiltration in the samples from the IR group was more pronounced than that in the S and E groups (p = 0.003 and p = 0.026, respectively), the infiltration levels were significantly diminished in the samples of the IR + E group compared to the IR group (p = 0.026) (Table 1 and Figure 2–5). Regarding interstitial edema, the IR group showed significantly higher scores than the S and E groups (p < 0.001 for both). Although the IR + E group presented with higher edema scores than the S and E groups (p = 0.006 and p = 0.018, respectively), the score was significantly lower than that of the IR group (p = 0.002). No statistically significant difference in hemorrhage scores was observed across the experimental groups (p = 0.540) (Table 1 and Figure 2–5). Table 1Histopathological Findings in H&E Stained Muscle Tissue Specimens [Median (25th–75th Percentiles)]Group S (n=6)Group E (n=6)Group IR (n=6)Group IR+E (n=6)P-valueHemorrhage0.00 (0–0.25)0.00 (0–0)0.00 (0–1)0.00 (0–0.25)0.540Neutrophil Infiltration0.00 (0–0.25)0.50 (0–1)1.00 (1–1.50)*, **0.50 (0–1)***0.019Disorganization and Degeneration of Muscle Fibers0.00 (0–1)0.00 (0–0.25)2.50 (1.75–3)*, **1.50 (1–2)*, **, ***<0.001Interstitial Edema0.00 (0–0.25)0.00 (0–1)2.50 (1.75–3)*, **1.00 (1–1.25)*, **, ***<0.001Total muscle injury score0.00 (0–2.25)1.00 (0.75–1.25)6.50 (4.50–8.25)*, **3.00 (2.75–4.25)*, **,***<0.001Notes: Data are presented as Median (25th–75th percentiles). Kruskal Wallis test was used for statistical analysis; significance level was set at p <0.05. *p < 0.05: Significant difference compared to the Sham Group (S). **p <0.05: Significant difference compared to E group. ***p <0.05: Significant difference compared to IR group. Each value represents an independent biological replicate (n = 6 per group). Histopathological Findings in H&E Stained Muscle Tissue Specimens [Median (25th–75th Percentiles)] Notes: Data are presented as Median (25th–75th percentiles). Kruskal Wallis test was used for statistical analysis; significance level was set at p <0.05. *p < 0.05: Significant difference compared to the Sham Group (S). **p <0.05: Significant difference compared to E group. ***p <0.05: Significant difference compared to IR group. Each value represents an independent biological replicate (n = 6 per group). In terms of total muscle injury scores, there was a statistically significant difference among the groups (p<0.001). The IR group demonstrated significantly elevated total muscle injury score in comparison to both the S and E groups (p < 0.001 for both). While the IR + E group also presented with higher scores than the S and E groups (p = 0.008 and p = 0.013, respectively), these scores were significantly lower when compared to the IR group (p = 0.002) (Table 1). Biochemical Results Comparative analysis of oxidative biomarkers indicated significant inter-group variations, as summarized in Table 2. Analysis of skeletal muscle tissue revealed significant inter-group variations in MDA levels (p < 0.001). Specifically, the IR group exhibited markedly elevated MDA concentrations relative to both the S and E groups (all p < 0.001). In contrast, the IR + E group exhibited significantly lower MDA levels than the IR group (p = 0.003) (Figure 6). Table 2Oxidative Status Parameters in Muscle Tissue [Mean ± SEM]Group S (n=6)Group E (n=6)Group IR (n=6)Group IR+E (n=6)P-valueMDA (nmol/gram, tissue)203.31±24.80270.93±32.19587.05±175.54*, **317.91±136.01***<0.001CAT (U/mg. protein)1.12±0.351.10±0.480.41±0.28*, **0.66±0.210.004SOD (U/mg. protein)14.40±2.5215.77±1.1712.01±3.5114.34±0.780.064GSH (nmol/gram, tissue)45.39±10.0945.11±9.5632.10±9.9537.04±8.480.068Notes: Data are presented as Mean ± Standard Error of the Mean (SEM). ANOVA test was used for statistical analysis; significance level was set at p <0.05. *p < 0.05: Significant difference compared to the Sham Group (S). **p <0.05: Significant difference compared to E group. ***p <0.05: Significant difference compared to IR group. Each value represents an independent biological replicate (n = 6 per group). Oxidative Status Parameters in Muscle Tissue [Mean ± SEM] Notes: Data are presented as Mean ± Standard Error of the Mean (SEM). ANOVA test was used for statistical analysis; significance level was set at p <0.05. *p < 0.05: Significant difference compared to the Sham Group (S). **p <0.05: Significant difference compared to E group. ***p <0.05: Significant difference compared to IR group. Each value represents an independent biological replicate (n = 6 per group). Comparison of MDA levels among experimental groups. Bars represent mean ± SEM (n = 6 per group, independent observations). * p<0.05: significant difference compared with the Group S; ** p<0.05: significant difference compared with the Group E; *** p<0.05: significant difference compared with the Group IR. Regarding antioxidant enzyme kinetics, CAT activity also differed significantly across the experimental groups (p = 0.004). A significant decline in CAT activity was noted in the IR group compared to the S and E groups (p = 0.011 and p = 0.013, respectively). Although an upward trend in CAT activity was observed in the IR + E group relative to the IR group, this increment did not reach statistical significance (Figure 7). Comparison of CAT enzyme activities among experimental groups. Bars represent mean ± SEM (n = 6 per group, independent observations). * p<0.05: significant difference compared with the Group S; ** p<0.05: significant difference compared with the Group E. No statistically significant differences were detected in SOD activity and GSH levels between the groups (p = 0.064 and p = 0.068, respectively). Nevertheless, a relative reduction in GSH levels was evident in the IR group, whereas a partial recovery was observed in the IR + E group (Figures 8 and 9). Comparison of SOD enzyme activities among experimental groups. Bars represent mean ± SEM (n = 6 per group, independent observations). Comparison of GSH levels among experimental groups. Bars represent mean ± SEM (n = 6 per group, independent observations). The absence of statistically significant changes in SOD activity and GSH levels may reflect the differential sensitivity and temporal response of endogenous antioxidant systems to ischemia–reperfusion injury. These parameters may require longer reperfusion periods or more extensive oxidative stress to exhibit measurable alterations. Additionally, tissue-specific antioxidant responses in skeletal muscle may differ from those observed in other organs, suggesting a selective modulation of oxidative pathways. Discussion The findings of the present study demonstrate that emodin administration exerts a protective effect against skeletal muscle ischemia-reperfusion injury in a rat model. Histopathological analysis revealed that the I/R-induced alterations, characterized by myofiber disorganization, cellular degeneration, interstitial edema, and neutrophilic infiltration, were significantly attenuated in the emodin-treated group. Although emodin did not entirely eliminate tissue injury, it markedly reduced the severity of architectural damage and the extent of the inflammatory response in the affected skeletal muscle. Biochemically, emodin administration suppressed oxidative lipid damage, as evidenced by a significant reduction in MDA levels compared to the untreated IR group. CAT activity, which was depleted following I/R injury, exhibited partial recovery upon emodin treatment. In contrast, SOD activity and GSH content remained largely unaffected. These findings suggest that the primary antioxidant mechanism of emodin in skeletal muscle is mediated through the inhibition of lipid peroxidation and the selective partial restoration of enzymatic defense, rather than a generalized augmentation of all endogenous antioxidant systems. The observed reduction in lipid peroxidation and partial restoration of CAT activity suggest that emodin may exert its protective effects through modulation of redox-sensitive signaling pathways. Although molecular analyses were not performed in the present study, previous studies suggest that emodin may inhibit NF-κB activation, thereby potentially reducing inflammatory cell infiltration and cytokine release.40,41 In parallel, activation of the Nrf2 pathway may contribute to enhanced antioxidant defense mechanisms, particularly CAT activity, which is consistent with the partial recovery identified in our biochemical findings.42 These proposed mechanisms provide a plausible explanation for the attenuation of neutrophilic infiltration and myofiber disorganization observed histopathologically, effectively linking oxidative stress modulation with structural preservation in skeletal muscle. These interpretations should be considered hypothesis-generating and necessitate confirmation through direct molecular investigations. Similar antioxidant effects of emodin have been documented across various organ systems. For instance, Chen et al demonstrated in HK-2 renal tubular cells subjected to hypoxia/reoxygenation that emodin pretreatment not only reduced MDA accumulation but also significantly restored CAT, SOD, and glutathione peroxidase activities. Compared with our findings in skeletal muscle, where CAT recovery remained incomplete and no significant alterations in SOD or GSH were observed, their results suggest that the antioxidant profile of emodin may be more pronounced in renal tissue.43 This discrepancy likely reflects organ-specific redox responses, as skeletal muscle possesses a distinct metabolic rate and antioxidant enzyme distribution compared to renal epithelia. In line with these observations, Huang et al confirmed in a myocardial I/R model that emodin reduced both MDA and ROS levels while restoring SOD activity, thereby attenuating infarct size and cardiomyocyte apoptosis.44 Combined with our data, these findings indicate that MDA reduction represents a consistent hallmark of emodin’s protective effect across diverse tissues; however, the recovery of enzymatic antioxidants, such as CAT and SOD, may vary depending on the specific organ system and experimental conditions. The lack of significant changes in SOD and GSH enzyme activities may also indicate that emodin’s antioxidant effect is primarily directed toward limiting lipid peroxidation rather than uniformly enhancing all endogenous antioxidant systems. This selective antioxidant profile suggests that emodin may act predominantly as a chain-breaking antioxidant, reducing membrane lipid damage rather than globally upregulating enzymatic antioxidant pathways. Additional studies support the role of emodin in mitigating oxidative stress and inflammation in diverse I/R models. In myocardial tissue, Zhang et al demonstrated that emodin reduced proinflammatory cytokines and cardiomyocyte injury by downregulating RUNX1, thereby decreasing miR-142-3p expression, upregulating DRD2, and ultimately inhibiting NF-κB activation.24 In a testicular torsion/detorsion model, He et al reported that emodin decreased MDA levels while increasing SOD activity and reducing LDH release, effects linked to the suppression of NLRP3-dependent pyroptosis.45 In the brain, Leung et al found that emodin increased GLT-1 expression and limited excitotoxic and oxidative injury after middle cerebral artery occlusion, supporting a neuroprotective role.46 In the kidney, Wang et al showed that emodin inhibited DRP1 phosphorylation at Ser616 through CaMKII signaling, thereby restraining mitochondrial fission, improving tubular function, and reducing apoptosis.27 From a clinical perspective, skeletal muscle I/R injury is frequently encountered in vascular surgery, including acute limb ischemia, revascularization procedures, and aortic interventions. The ability of emodin to attenuate oxidative damage and histopathological injury suggests its potential as an adjunctive therapeutic strategy to reduce reperfusion-related complications and improve tissue viability in these clinical scenarios. Taken together, these reports underscore that MDA reduction is a reproducible and robust hallmark of emodin’s protective effect across multiple organs, while the recovery of enzymatic antioxidants such as CAT and SOD appears to be tissue- and context-dependent.26,43,44 The partial CAT restoration observed in our skeletal muscle model, in contrast to the more complete recovery reported in renal and myocardial systems, highlights the need for further research into tissue-specific redox regulation and the pharmacodynamics of emodin.43,44 Importantly, the present study provides the first in-vivo evidence of emodin’s protective effects in a skeletal muscle I/R model, thereby offering novel insights into its potential tissue-specific actions. Limitations This study has certain limitations. First, the relatively small sample size and short reperfusion duration may limit the generalizability of the findings. Second, only a single dose and administration route of emodin were tested; consequently, dose-response relationships and alternative delivery methods were not evaluated. Third, mechanistic insights were inferred from biochemical and histopathological parameters, but molecular signaling pathways were not directly investigated. Future studies incorporating longer reperfusion times, different dosing strategies, and molecular analyses are needed to fully elucidate the protective mechanisms of emodin in skeletal muscle I/R injury. Additionally, the absence of molecular pathway analyses, such as those involving NF-κB and Nrf2 signaling, limits the ability to fully elucidate the underlying mechanisms of emodin’s protective effects. Future studies incorporating these molecular markers would provide a more comprehensive understanding of its role in I/R injury. Although the sample size (n = 6 per group) may be considered relatively small, it is consistent with commonly used experimental animal studies and complies with the resource equation method for ANOVA-based designs. Conclusion In conclusion, emodin provides partial but significant protection against skeletal muscle I/R injury by attenuating lipid peroxidation and partially restoring catalase activity. These findings suggest a selective antioxidant mechanism, potentially mediated through redox-sensitive signaling pathways. As the first in-vivo study demonstrating the effects of emodin in skeletal muscle I/R injury, this work highlights its potential as a tissue-specific therapeutic agent and supports further investigation into its molecular mechanisms and clinical applicability. Acknowledgments This work was supported by the Scientific Research Projects Coordination Unit of Gazi University under grant number TTU-2024-9231. Funding Statement No funding was received. Data Sharing Statement The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Ethics Approval and Consent to Participate Ethical approval for the study was obtained from the Animal Research Committee of Gazi University (Ankara, Turkey; approval no. G.Ü.ET-23-117). All experimental procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication No. 85-23, revised 2011) and were reported in compliance with the ARRIVE guidelines 2.0. Author Contributions All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work. Disclosure Dr Dilara Yiğit reports Support for the manuscript from Scientific Research Projects Coordination Unit of Gazi University, during the conduct of the study, outside the submitted work. The authors declare that they have no competing interests. References Associated Data Data Availability Statement The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.